Showing results (561-570 of 1,014) with videos related to
Sort By:
Pageof 102
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox)M F Brin, A Blitzer, S Fahn, et al.Neurology|January 1, 1990
Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American familyT G Nygaard, J M Trugman, J G de Yebenes, et al.The Journal of Pharmacy and Pharmacology|June 1, 1988
Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptorsJ K Chivers, W Gommeren, J E Leysen, et al.Psychopharmacology|January 1, 1984
Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in ratsN M Rupniak, G Kilpatrick, M D Hall, et al.Biochemical Pharmacology|October 1, 1983
Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptorsS Fleminger, N M Rupniak, M D Hall, et al.Neuroscience Letters|July 3, 1989
Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTPS Rose, M Nomoto, E Kelly, et al.Annals of Neurology|September 1, 1982
Pergolide in late-stage Parkinson diseaseA E Lang, N Quinn, S Brincat, et al.Brain Research|June 18, 1984
Duration of the first agonist EMG burst in ballistic arm movementsA Berardelli, J C Rothwell, B L Day, et al.Clinical Neuropharmacology|January 1, 1986
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic dataM H Marion, F Stocchi, N P Quinn, et al.Advances in Neurology|January 1, 1986
Urea-induced stimulus-sensitive myoclonus in the ratS Muscatt, J Rothwell, J Obeso, et al.Pageof 102